Cargando…
Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development
Heavy chain (Hc) heterodimers represent a majority of bispecific antibodies (bsAbs) under clinical development. Although recent technologies achieve high levels of Hc heterodimerization (HD), traces of homodimer contaminants are often present, and as a consequence robust purification techniques for...
Autores principales: | Ollier, Romain, Wassmann, Paul, Monney, Thierry, Ries Fecourt, Christelle, Gn, Sunitha, C A, Vinu, Ayoub, Daniel, Stutz, Cian, Gudi, Girish S, Blein, Stanislas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816383/ https://www.ncbi.nlm.nih.gov/pubmed/31462177 http://dx.doi.org/10.1080/19420862.2019.1660564 |
Ejemplares similares
-
Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies
por: Skegro, Darko, et al.
Publicado: (2017) -
A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species
por: Stutz, Cian, et al.
Publicado: (2020) -
BEAT(® )the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
por: Moretti, Pierre, et al.
Publicado: (2013) -
SPLICELECT™: an adaptable cell surface display technology based on alternative splicing allowing the qualitative and quantitative prediction of secreted product at a single-cell level
por: Aebischer-Gumy, Christel, et al.
Publicado: (2020) -
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity
por: Tustian, Andrew D., et al.
Publicado: (2016)